IBRX — IMMUNITYBIO INC

Ownership history in AlphaCore Capital LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which AlphaCore Capital LLC reported a position in IMMUNITYBIO INC (IBRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.3% (2025 Q2)
Avg. % of fund
0.23%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 3,000,544 +12,000 +0.4% 0.13% $5.9M $1.98
2025 Q3 ADDED 2,988,544 +13,666 +0.5% 0.25% $7.4M $2.46
2025 Q2 INITIATED 2,974,878 — — 0.30% $7.9M $2.64
% of Fund (quarterly)    IBRX price (monthly, adj. close)

Other funds also holding IBRX

As of 2025 Q4 — sorted by position size

Kercheville Advisors, LLC 3Y 1.12% Winning Points Advisors, LLC 3Y 0.54% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.23% Accurate Wealth Management, LLC 3Y 0.17% Virtus Investment Advisers, LLC 3Y 7Y 0.16% Clearwater Capital Advisors, LLC 3Y 7Y 0.14% SHEETS SMITH WEALTH MANAGEMENT 3Y 7Y 0.14% ALLEN HOLDING INC /NY 3Y 7Y 0.13% COLLECTIVE FAMILY OFFICE LLC 3Y 0.07% Voleon Capital Management LP 3Y 7Y 0.06%
← Back to AlphaCore Capital LLC Holdings